As shown in Table 1, compared to healthy controls and stable CHD, STEMI patients presented with higher admission glucose levels, increase of LPS, d-lactate and high-sensitivity C-reactive protein (hs-CRP), lower high-density lipoprotein levels, and compromised left ventricular ejection fraction (LVEF). The gene discussed is CRP; the disease is coronary artery disorder.